Short-Term Monotherapy With IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor, in Patients With Chronic Hepatitis C Virus Infection

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01521-12